Cowen and Company’s Nova Vision Acquisition Corp. Rights NOVVR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,000
Closed -$7.25K 741
2023
Q1
$7.25K Sell
25,000
-35,600
-59% -$6.34K ﹤0.01% 418
2022
Q4
$7.27K Sell
60,600
-39,500
-39% -$4.68K ﹤0.01% 436
2022
Q3
$15K Buy
100,100
+49,201
+97% +$5.91K ﹤0.01% 383
2022
Q2
$5K Buy
50,899
+899
+2% +$113 ﹤0.01% 574
2022
Q1
$9K Sell
50,000
-90,299
-64% -$21.9K ﹤0.01% 519
2021
Q4
$46K Buy
140,299
+100,299
+251% +$34.2K ﹤0.01% 451
2021
Q3
$14K Buy
+40,000
New +$14K ﹤0.01% 509

Other funds holding NOVVR

Cowen and Company's NOVVR Position: Q2 2023 in Review

Cowen and Company sold out of Nova Vision Acquisition Corp. Rights (NOVVR) in Q2 2023, closing a stake of 25,000 shares — an estimated $7.25K sold.

Cowen and Company first reported a position in NOVVR in Q3 2021 and held it in 7 quarters. The position peaked at $46K in Q4 2021. 18 funds tracked by Wall St. Rank hold NOVVR as of Q2 2023.

  • Cowen and Company reported no remaining Nova Vision Acquisition Corp. Rights position as of Q2 2023 after selling out during the quarter.
  • Cowen and Company sold 25,000 Nova Vision Acquisition Corp. Rights shares in Q2 2023, an estimated $7.25K.
  • Cowen and Company first reported a position in Nova Vision Acquisition Corp. Rights in Q3 2021 and held it in 7 quarters.
  • Cowen and Company's Nova Vision Acquisition Corp. Rights position peaked at $46K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Nova Vision Acquisition Corp. Rights as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.